Editorial brief · Condition
Stimulant use disorder.
Stimulant use disorder covers problematic use of cocaine, meth, prescription amphetamines, and similar drugs — usually without the physical withdrawal of alcohol or opioids, but with serious mental health and behavioral fallout.
How luxury centers address it
Stimulant addiction responds differently to residential treatment than alcohol or opioids. Withdrawal is mostly psychological — exhaustion, depression, inability to feel pleasure, intense cravings — and isn't usually medically dangerous. But the recovery window is long, with thinking and mood problems lasting weeks or months, and relapse rates are high without sustained support.
There's no single proven medication for stimulant addiction yet, which makes therapy and structure more central than in opioid or alcohol treatment. Top residential programs combine reward-based approaches (the most evidence-backed method for stimulants), cognitive behavioral therapy, and a structured daily routine that addresses the disrupted sleep, appetite, and mood that early recovery brings.
Some stimulant users — especially those using prescription amphetamines or meth — develop symptoms that look like bipolar disorder or psychosis and need careful evaluation to sort out what's what. Programs with strong psychiatric teams handle this much better than high-volume addiction programs that treat stimulant use as straightforward.
Before admission
Questions worth asking.
- How long is a typical stay for stimulant addiction, and what does the step-down plan look like?
- Does the clinical team use reward-based (contingency management) approaches specifically?
- If someone shows signs of psychosis or major mood swings, how do you figure out what's causing them?
- What's your approach to the long recovery window — the 8-to-12-week stretch when relapse risk is highest?
Related conditions
Browse the catalogue